Security Snapshot

HEALTHCARE REALTY TRUST - COMMON STOCK (HR) Institutional Ownership

CUSIP: 421946104

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

1

Shares (Excl. Options)

1

Price

$24.00

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COMMON STOCK
Symbol
HR on NYSE
Price per share
$24.00
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1
Total reported value
$24
Share change
0
Number of holders
1
Price from insider filings
$24.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • HR - HEALTHCARE REALTY TRUST - COMMON STOCK is tracked under CUSIP 421946104.
  • 1 institution reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 1 to 1 between Q3 2025 and Q4 2025.
  • Reported value moved from $24 to $24.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1 institution filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 421946104?
CUSIP 421946104 identifies HR - HEALTHCARE REALTY TRUST - COMMON STOCK in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 1 institutional investors reported holding 1 shares of HEALTHCARE REALTY TRUST - COMMON STOCK (HR).

Institutional Holders of HEALTHCARE REALTY TRUST - COMMON STOCK (HR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1 $24 $24.00 1
2025 Q3 1 $24 $24.00 1
2025 Q2 1 $24 $24.00 1
2025 Q1 1 $24 $24.00 1
2024 Q4 3,151 $53,024 +$53,000 $20.41 2
2024 Q3 1 $24 $24.00 1
2024 Q2 1 $24 $24.00 1
2024 Q1 2 $38 -$17,440 $19.00 2
2023 Q4 2,002 $34,481 $17.22 4
2023 Q3 2,002 $30,309 -$1,205,241 $15.14 4
2023 Q2 65,907 $1,243,144 +$457,719 $19.00 5
2023 Q1 41,645 $805,005 -$3,167,787 $21.66 2
2022 Q4 206,039 $3,970,376 -$325,180 $19.27 4
2022 Q3 120,517 $2,765,000 -$4,387,706,901 $27.20 5
2022 Q2 161,580,398 $4,388,870,702 +$50,071,078 $27.20 269
2022 Q1 159,885,140 $4,395,430,327 +$462,975,721 $27.48 299
2021 Q4 142,684,323 $4,514,426,836 -$65,365,340 $31.64 294
2021 Q3 144,772,386 $4,312,863,363 +$79,732,343 $29.78 271
2021 Q2 142,188,238 $4,294,349,677 +$118,670,109 $30.20 275
2021 Q1 138,260,643 $4,192,494,619 +$74,612,927 $30.32 285
2020 Q4 136,402,988 $4,036,969,505 +$129,795,227 $29.60 303
2020 Q3 132,918,159 $4,003,666,175 -$32,048,799 $30.12 283
2020 Q2 134,040,432 $3,924,928,039 +$97,729,942 $29.29 278
2020 Q1 130,769,751 $3,652,065,425 +$58,207,421 $27.93 257
2019 Q4 128,431,711 $4,285,892,858 +$75,228,999 $33.37 259
2019 Q3 126,098,518 $4,223,540,871 -$7,897,183 $33.50 254
2019 Q2 126,418,459 $3,959,476,575 +$103,938,211 $31.32 234
2019 Q1 123,732,510 $3,973,132,348 +$41,123,464 $32.11 252
2018 Q4 122,528,958 $3,484,630,470 +$8,036,348 $28.44 234
2018 Q3 122,187,279 $3,574,705,316 +$112,211,157 $29.26 235
2018 Q2 118,413,806 $3,443,417,982 -$113,164,642 $29.08 240
2018 Q1 122,744,250 $3,401,077,571 +$6,405,795 $27.71 232
2017 Q4 122,367,633 $3,929,945,668 +$85,476,843 $32.12 230
2017 Q3 119,463,378 $3,863,599,989 +$147,459,366 $32.34 215
2017 Q2 114,815,672 $3,920,553,994 +$102,007,497 $34.15 220
2017 Q1 111,909,030 $3,636,877,271 +$486,244,885 $32.50 223
2016 Q4 111,092,482 $3,368,091,289 -$50,565,662 $30.32 233
2016 Q3 117,245,131 $3,991,809,072 -$42,093,202 $34.06 230
2016 Q2 118,503,042 $4,146,059,789 +$451,364,964 $34.99 244
2016 Q1 105,801,691 $3,267,710,520 +$107,940,859 $30.89 215
2015 Q4 102,372,767 $2,898,520,348 +$48,164,530 $28.32 211
2015 Q3 100,882,925 $2,506,760,566 +$28,236,428 $24.85 202
2015 Q2 99,938,173 $2,324,333,990 +$55,232,442 $23.26 199
2015 Q1 97,423,088 $2,706,971,783 +$7,575,637 $27.78 203
2014 Q4 97,090,304 $2,653,153,408 -$37,055,605 $27.32 191
2014 Q3 98,676,645 $2,336,643,490 +$30,433,510 $23.68 182
2014 Q2 97,379,402 $2,475,190,288 +$48,663,199 $25.42 187
2014 Q1 95,432,642 $2,304,639,597 +$69,102,583 $24.15 182
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .